Crescent Biopharma, Inc. (CBIO) short volume · rev $10.8M
Crescent Biopharma, Inc. FINRA short-volume cache. Latest 2026-10-21.
| Date | Short | Total | Short % |
|---|---|---|---|
| 2026-10-21 | 48,976 | 82,845 | 59.1% |
| 2026-10-20 | 49,799 | 99,803 | 49.9% |
| 2026-10-19 | 44,185 | 88,301 | 50.0% |
| 2026-10-16 | 42,828 | 61,777 | 69.3% |
| 2026-10-15 | 42,887 | 118,488 | 36.2% |
| 2026-10-14 | 50,318 | 79,355 | 63.4% |
| 2026-10-13 | 44,208 | 71,032 | 62.2% |
| 2026-10-12 | 45,984 | 55,620 | 82.7% |
| 2026-10-09 | 51,528 | 179,051 | 28.8% |
| 2026-10-08 | 71,672 | 105,872 | 67.7% |
CBIO short volume FAQ
What was CBIO's latest FINRA short volume?
On Oct 21, 2026, cached FINRA short volume for Crescent Biopharma, Inc. (CBIO) was 48,976 shares, 59.1% of 82,845 total volume.
How many CBIO short-volume sessions are listed on this page?
This page lists 10 cached FINRA short-volume sessions for Crescent Biopharma, Inc. (CBIO), from Oct 8, 2026 through Oct 21, 2026.
How did CBIO short volume percent change from the prior cached session?
Cached FINRA short volume for Crescent Biopharma, Inc. (CBIO) moved from 49.9% on Oct 20, 2026 to 59.1% on Oct 21, 2026, up 9.2 percentage points.
What was the highest CBIO short volume percent on this page?
The highest cached FINRA short volume on this page is 82.7% of total volume on Oct 12, 2026.
Where is CBIO listed?
Crescent Biopharma, Inc. (CBIO) common stock is listed on NASDAQ.
What is CBIO's latest revenue?
Latest cached Crescent Biopharma, Inc. (CBIO) revenue for Dec 31, 2025 was $10.8M. Statements: https://lician.com/financials/cbio
What is the average CBIO short volume percent on this page?
Across 10 cached sessions on this page, Crescent Biopharma, Inc. (CBIO) short volume averaged 56.9% of total volume.
Where is CBIO short volume listed?
Cached FINRA short volume for Crescent Biopharma, Inc. (CBIO) is listed at https://lician.com/short-interest/cbio.
Not investment advice. Cached rows, not a live tape.